[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
November 17, 1999

Fetal Surgery for MyelomeningocelePromise, Progress, and Problems

Author Affiliations

Author Affiliation: Departments of Obstetrics and Gynecology and Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex.

JAMA. 1999;282(19):1873-1874. doi:10.1001/jama.282.19.1873

Few can resist the siren call of fetal surgery. The media are fascinated. Physicians in obstetrics, pediatric surgery, and, especially, reproductive genetics envision fetal surgery and therapy as the natural extension of prenatal genetic diagnosis. In utero diagnosis of birth defects is an attractive option and becoming more widespread. However, 30 years after the first in utero diagnosis,1 the major benefit of prenatal genetic diagnosis is better reproductive counseling for the parents. While this is laudable, physicians like to treat.

First Page Preview View Large
First page PDF preview
First page PDF preview
×